Sydney, Australia / New Zealand.
An exciting opportunity has become available for an experienced Market Access Manager to join our Market Access team on a 12-month contract (Maternity leave cover), based in Sydney, NSW and reporting to the Head of Market Access & Healthcare Affairs.
This role offers a unique opportunity to be responsible for reimbursement for a key launch brand for Boehringer Ingelheim in Australia. Working within a highly collaborative environment, you will play a key role in ensuring innovation of new medicines are valued appropriate and positioned for successful reimbursement.
As a strategic market access partner, you will work collaborative with Medical, Regulatory Affairs, Clinical Development, Commercial, Public Affairs and Patient Advocacy to drive access and prepare the team for a successful launch.
This role provides an outstanding opportunity for a market access professional who enjoys working in a dynamic environment, influencing cross-functional decision-making, and contributing to the future success of Boehringer Ingelheim’s innovative therapies.
Belangrijkste verantwoordelijkheden:
- Implement market access strategies for pipeline assets across Australia and New Zealand, aligned with local and global business objectives.
- Lead reimbursement submissions, evidence-generation and value demonstration strategies to support PBS, MSAC and PHARMAC funding pathways.
- Work collaboratively with regional and corporate market access function in contributing to the annually business plan
- Identify evidence gaps and oversee the development of supporting evidence through research initiatives, including burden of disease, patient experience, quality of life and societal impact studies.
- Provide strategic advice relating to pricing and competitors in the market
- Management of monthly SPA invoicing and any related RSAs
- Generate strategic insights on reimbursement policy, payer priorities, competitive dynamics and market access trends to support business planning.
- Contribute to payer engagement activities, including advisory boards and stakeholder consultations, to strengthen value propositions and access strategies.
- Collaborate closely with cross-functional teams to ensure alignment between market access, regulatory, medical and commercial plans.
- Support reimbursement submissions throughout the asset lifecycle, including preparation for pre-submission meetings, submission development and post-submission activities.
- Build and maintain strong relationships with external stakeholders, including government agencies, payers, clinicians and patient advocacy organisations.
- Contribute to PBAC submissions where required, including the development of key submission components in partnership with the broader Market Access team.
Requirements:
- A degree in Life Sciences, Pharmacy, Health Economics or a related discipline; postgraduate qualifications will be highly regarded.
- At least 2-3 years of experience direct experience writing certain sections of submissions to the PBAC, and/or MSAC.
- Demonstrated experience developing and leading reimbursement submissions, particularly within PBAC and/or MSAC processes.
- Strong knowledge of the Australian and New Zealand healthcare systems, reimbursement pathways and policy environment.
- A solid understanding of health economics and outcomes research, with the ability to critically evaluate economic models and evidence.
- Excellent communication skills and the ability to translate complex clinical and economic evidence into compelling value propositions for payers and decision makers.
- Experience influencing and collaborating with diverse cross-functional stakeholders in a matrix environment.
- Strong strategic capability and the ability to make effective decisions in situations where evidence and data continue to evolve.
Position Area
Human Pharma
Position Location
NSW
Schedule
Full-Time
This job is posted by Boehringer Ingelheim.
This link brings you to the website of Boehringer Ingelheim.
Vermeld alstublieft dat u de vacature heeft gevonden via EuropeanHealthEconomics.com. Dank je wel en veel succes!
